Insulin Glulisine in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal Insulin

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
The purpose of this study is to compare the change in glycemic control, as measured by hemoglobin A1c (HbA1c) from baseline to study week 24, in subjects receiving insulin glulisine as mealtime insulin following a variable bolus insulin regimen (based on carbohydrate counting) versus a fixed bolus insulin regimen, with insulin glargine as basal insulin in both arms of the study.
Epistemonikos ID: a90ec7f14ffa27209a4164e586da0d54672d31aa
First added on: May 04, 2024